🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 13 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/06/2021 78,19 79,92 77,34 79,60 +1,02% 3,30% 553.500
21/06/2021 79,53 79,69 77,38 78,80 -0,69% 2,90% 1.019.800
18/06/2021 79,23 79,94 78,02 79,35 -0,92% 2,42% 1.431.000
17/06/2021 81,77 82,56 79,62 80,09 -2,50% 3,60% 611.600
16/06/2021 82,84 83,30 80,53 82,14 -1,20% 3,34% 798.000
15/06/2021 86,69 90,00 83,01 83,14 -3,46% 8,06% 1.281.300
14/06/2021 86,05 87,67 85,54 86,12 +0,14% 2,48% 793.000
11/06/2021 86,00 86,78 84,75 86,00 -0,86% 2,36% 1.126.900
10/06/2021 82,28 87,18 80,60 86,75 +4,88% 8,00% 1.404.900
09/06/2021 79,45 84,11 79,45 82,71 +3,85% 5,87% 1.542.900
08/06/2021 80,02 81,30 78,22 79,64 +0,06% 3,85% 930.900
07/06/2021 73,10 80,91 72,30 79,59 +9,07% 11,78% 2.248.900
04/06/2021 73,92 73,92 72,21 72,97 -1,07% 2,31% 803.300
03/06/2021 75,00 75,81 73,56 73,76 -2,25% 3,00% 638.000
02/06/2021 75,73 76,47 74,62 75,46 -0,26% 2,44% 907.500
01/06/2021 76,01 76,58 73,89 75,66 +0,01% 3,54% 907.000
28/05/2021 76,86 79,13 75,49 75,65 -1,57% 4,74% 1.199.700
27/05/2021 74,71 77,00 73,19 76,86 +2,55% 5,10% 4.661.300
26/05/2021 75,50 75,98 73,81 74,95 -0,20% 2,87% 899.200
25/05/2021 77,12 77,35 74,50 75,10 -2,73% 3,70% 944.600
24/05/2021 79,76 79,85 76,73 77,21 -2,98% 3,91% 1.137.900
21/05/2021 80,21 80,97 79,35 79,58 -0,79% 2,02% 1.095.100
20/05/2021 77,14 81,21 76,60 80,21 +4,28% 5,98% 1.567.300
19/05/2021 79,13 79,25 75,14 76,92 -5,55% 5,19% 1.964.700
18/05/2021 79,27 85,48 77,25 81,44 +8,40% 10,38% 4.010.900
17/05/2021 75,19 76,22 74,44 75,13 -1,21% 2,37% 571.400
14/05/2021 72,67 76,10 72,35 76,05 +4,88% 5,16% 1.070.500
13/05/2021 74,22 74,49 70,18 72,51 -1,87% 5,81% 1.079.100
12/05/2021 70,28 74,40 69,78 73,89 +4,04% 6,57% 1.420.300
11/05/2021 68,28 71,32 67,68 71,02 +1,41% 5,33% 1.324.700